Relafen 750, or Relafen, or Naproxcinod, or the medication represents a targeted approach to pain control, viewed through a biochemical pharmacy perspective. A formulation, comprising naproxcinod, seeks to affect cyclooxygenase (COX) activity, specifically COX-2, although demonstrating minimal in